Company news

AngioDynamics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference

July 28, 2021

AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results

July 12, 2021

AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021

July 7, 2021

AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021

June 23, 2021

AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System

June 7, 2021

AngioDynamics to Present at the UBS Virtual Global Healthcare Conference

May 16, 2021

AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System

April 11, 2021

AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance

March 29, 2021

AngioDynamics to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum

March 14, 2021

AngioDynamics to Report Fiscal 2021 Third Quarter Financial Results on March 30, 2021

March 8, 2021

AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference

March 8, 2021

AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference

February 28, 2021

AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs

January 31, 2021

AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results

January 6, 2021

AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference

January 3, 2021

AngioDynamics to Report Fiscal 2021 Second Quarter Financial Results on January 7, 2021

December 8, 2020

AngioDynamics Announces Presentation of Positive Safety, Efficacy Results from RAPID Outcomes Database

November 11, 2020

AngioDynamics Reports Fiscal 2021 First Quarter Financial Results

September 28, 2020

AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States

September 20, 2020

AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020

September 16, 2020

AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System

August 16, 2020

AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference

August 2, 2020

AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

July 15, 2020

AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020

June 22, 2020

AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference

June 7, 2020

AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results

April 6, 2020

AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020

March 9, 2020

AngioDynamics to Present at Two Investor Conferences in March

February 26, 2020

AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer

February 5, 2020

AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System

January 15, 2020

AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results

January 6, 2020

AngioDynamics to Report Fiscal 2020 Second Quarter Financial Results on January 7, 2020

December 9, 2019

AngioDynamics Announces Departure of CFO and Appointment of Interim CFO

October 21, 2019

AngioDynamics Reports Fiscal 2020 First Quarter Financial Results

October 2, 2019

AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology

October 2, 2019

AngioDynamics Awarded Premier’s Nationally Outsourced Implantable Infusion Port Agreement

September 8, 2019

AngioDynamics Announces Appointment of Former Johnson & Johnson Executive Karen Licitra to its Board of Directors

July 30, 2019

AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer

April 16, 2019

AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million

April 16, 2019

AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results

April 1, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 90 decks. Every deck is listed under its year.